NCT06105047Completed
Validation of a Remediation Method for Memory Disorders Using Motor and Emotional Encoding in Patients With Alzheimer's Disease
Validation of a Remediation Method for Memory Disorders Using Motor and Emotional Encoding in Patients With Alzheimer's Disease (AD)
Source: ClinicalTrials.gov · Last updated 25 Jun 2025
Brief summary (registry, in English)
Memories are more robust when they are multitraced. This means that the more a piece of information is mediated by different sensory inputs, the more resistant it is to being forgotten. Many works in the field of embodied cognition show that new learnings are better recalled over the long term when they are learned during body mobilization. Other works show that musical stimulation could be a good way of eliciting physiological and emotional states more favorable to the memorization of new contents. However, to date, no studies have examined the positive effects of these two tools combined in Alzheimer's disease. The investigators suggest that it is possible to optimize memory in Alzheimer's disease by referring to their motor and emotional resources. The hypothesis is that information will be better recalled with multimodal enriched learning.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 40 (actual)
- First submitted
- 23 Oct 2023
- Start date
- 22 Jan 2024
- Primary completion date
- 9 May 2025
- Lead sponsor
- Centre Hospitalier Universitaire de Saint Etienne
- Diseases
- Alzheimer disease
- NCT number
- NCT06105047
What you commit to
- Study type: Interventional
- Participants enrolled: 40
- From 22 Jan 2024 to the primary completion date, 9 May 2025
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Participation in a study on a drug/medical device/care technique likely to affect cognitive functions
Other illness
- Uncorrected perceptual disorders
- Other neurological or psychiatric history
Other
- Inability to communicate
- Delusional or psychotic state
- Person unable to give informed consent
- Refusal to participate
Who the study is looking for
- Diagnosis of Alzheimer's disease by one of the consulting physicians, neurologist and/or geriatrician of whom the patient has been informed.
- Early stage (MMSE ≥ 22)
- Neuropsychological assessment within 6 months of inclusion.
- Affiliation with a social security scheme
- Age equal to or greater than 60
- French mother tongue
- Agreement to participate / signature of consent form
Age in the registry: 60 years to 90 years · Sex: All · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Chu Grenoble Coordinator of this site? Confirm its status | Grenoble | France | Unknown status |
| Chu de Saint Etienne Coordinator of this site? Confirm its status | Saint-Etienne | France | Unknown status |
| HCL Coordinator of this site? Confirm its status | Villeurbanne | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.